Last reviewed · How we verify
NCT05946031
Testing the ETM: Examination and Comparison of Different Methods
EARLY_PHASE1 trial testing Reat ETM in Cigarette Smoking in 87 participants. Completed in 14 August 2025.
14 August 2025
Quick facts
| Lead sponsor | Virginia Polytechnic Institute and State University |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 87 |
| Start date | 28 July 2024 |
| Primary completion | 14 August 2025 |
| Estimated completion | 14 August 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Reat ETM — full drug profile →
- Hypothetical ETM — full drug profile →
Conditions studied
- Cigarette Smoking — all drugs for Cigarette Smoking →
Sponsor
Virginia Polytechnic Institute and State University
Who can join
21 and older, any sex, with Cigarette Smoking. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will experimentally assess the comparability of in-lab and remote procedures with hypothetical and real ETM purchase outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05946031
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cigarette Smoking
Currently open trials in the same condition.
- NCT07161050 — Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing · NA · recruiting
- NCT07014124 — Smoking Cessation for Fathers of Sick Children · NA · recruiting
- NCT06678789 — Evaluation of Low and High Nicotine Tobacco Free Nicotine Pouches · NA · recruiting
- NCT06609083 — Effect of Cannabis on Cigarette Use Behavior · Phase 1 · recruiting
- NCT05587361 — Beta-Adrenergic Modulation of Drug Cue Reactivity · Phase 4 · recruiting
Other Virginia Polytechnic Institute and State University trials
Trials by the same sponsor.
- NCT07521072 — Testing an Intervention for College Students With Food Insecurity and Binge Eating · EARLY_PHASE1 · not yet recruiting
- NCT07042373 — Effects of Tobacco Abuse Liability-dependent Taxes in the ETM · NA · not yet recruiting
- NCT07158749 — Generalized and Domain-Specific Episodic Thinking for Smoking Cessation · NA · not yet recruiting
- NCT07457710 — Remote Haptic Rehabilitation for Parkinson's Disease · NA · not yet recruiting
- NCT05103514 — The Longitudinal Impact of SES and the CNDS on Recovery From SUD · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05946031 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Virginia Polytechnic Institute and State University
- Last refreshed: 2 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05946031.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing